New injection aims to smooth cellulite dimples
NCT ID NCT05836779
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests an investigational drug called CBL-514, given as an injection into areas of cellulite on the thighs. The goal is to see if it can safely reduce the severity of cellulite dimpling. The trial involves women aged 18 to 64 with mild to moderate cellulite. Researchers will measure changes in skin appearance using a standard cellulite severity scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CBL-514 injection
- What this could lead to
- If effective, this could offer a non-surgical treatment to reduce the appearance of cellulite on the thighs.
- What could go wrong
- This is an early-phase, small study (23 participants) with no placebo group, so results may not prove effectiveness. Side effects from the injection are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELLULITE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site 1
Encino, California, 91436, United States
-
Investigational Site 2
New York, New York, 10022, United States
-
Investigational Site 3
San Diego, California, 92121, United States
-
Investigational Site 4
Coral Gables, Florida, 33146, United States
-
Investigational Site 6
Encinitas, California, 92024, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.